Showing results (1-10 of 114) with videos related to
Sort By:
Pageof 12
L'Encephale|July 6, 2013
[Sexual dysfunction and depression: Validity of a French version of the ASEX scale]M Briki, E Haffen, J Monnin, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 3, 2014
Pilot study of feasibility of the effect of treatment with tDCS in patients suffering from treatment-resistant depression treated with escitalopramD Bennabi, M Nicolier, J Monnin, et al.Current Pharmaceutical Design|February 3, 2007
Pharmacogenetics and drug therapy in psychiatry--the role of the CYP2D6 polymorphismP Vandel, J M Talon, E Haffen, et al.L'Encephale|June 30, 2000
[Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism]K Reggiani, P Vandel, E Haffen, et al.Human Psychopharmacology|July 15, 2004
Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patientsP Vandel, E Haffen, S Nezelof, et al.Therapie|September 1, 2000
Drug extrapyramidal side-effects or not: is there a dextromethorphan phenotype difference?P Vandel, E Haffen, S Vandel, et al.L'Encephale|December 22, 1999
[Treatment of depression secondary to psychotic disorders]D Sechter, P VandelPharmacopsychiatry|December 22, 1999
Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotypeE Haffen, P Vandel, F Broly, et al.La Revue Du Praticien|February 7, 1998
[Biological rhythms and psychiatric syndromes]P Vandel, J Boiteux, D SechterPageof 12